Stay updated on Pembrolizumab SubQ vs IV in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T14:08:31.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.5%
    Check dated 2026-10-25T13:23:29.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T14:51:47.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T14:03:48.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study's history, and the older revision v3.6.6 was removed from the list.
    Difference
    0.1%
    Check dated 2026-09-20T20:27:04.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates a new page revision deployed on the site, with no impact on the actual study data or the information presented about the trial.
    Difference
    0.1%
    Check dated 2026-08-30T21:57:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab SubQ vs IV in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.